Carillo, Gary B.
HRN: 22-24-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2023
MUPIROCIN 2%, 15G (TUBE)
06/06/2023
06/13/2023
TOPICAL
1g
Bid
S/p Cheiloplasty
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes